StonvexLoading…
StonvexStonvexStonvexCore line items from CSGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $313.73M | $1.22B | $900.20M | $596.58M |
Operating Income | $35.07M | $118.75M | $89.70M | $59.24M |
Net Income | $23.89M | $55.88M | $48.88M | $28.40M |
EPS (Diluted) | $0.83 | $1.98 | $1.74 | $1.01 |
Total Assets | $1.48B | $1.54B | $1.47B | $1.42B |
Total Liabilities | $1.19B | $1.26B | $1.18B | $1.13B |
Cash & Equivalents | $147.32M | $180.01M | $158.38M | $145.88M |
Free Cash Flow OCF − CapEx | $-2.90M | $141.39M | $85.58M | $41.64M |
Shares Outstanding | 28.51M | 28.37M | 28.61M | 28.88M |